APA (7th ed.) Citation

AA, P., ES, K., PG, S., AC, C., WF, N., JM, F., . . . F, F. (2025). The efficacy and safety of specific therapies for cardiac Transthyretin-mediated amyloidosis: A systematic review and meta-analysis of randomized trials. BMC cardiovascular disorders, 25(1), 296. https://doi.org/10.1186/s12872-025-04653-4

Chicago Style (17th ed.) Citation

AA, Prata, et al. "The Efficacy and Safety of Specific Therapies for Cardiac Transthyretin-mediated Amyloidosis: A Systematic Review and Meta-analysis of Randomized Trials." BMC Cardiovascular Disorders 25, no. 1 (2025): 296. https://doi.org/10.1186/s12872-025-04653-4.

MLA (9th ed.) Citation

AA, Prata, et al. "The Efficacy and Safety of Specific Therapies for Cardiac Transthyretin-mediated Amyloidosis: A Systematic Review and Meta-analysis of Randomized Trials." BMC Cardiovascular Disorders, vol. 25, no. 1, 2025, p. 296, https://doi.org/10.1186/s12872-025-04653-4.